Safety and feasibility of exhaled breath condensate collection in ventilated infants and children

European Respiratory Journal

Volumn 28, Issue 3, 2006, Pages 479-485

  Muller, W G ^a   Morini, F ^b   Eaton, S ^b   Peters, M ^a   Jaffe, A ^a  

^a Portex Anaesthesia   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

8 isoprostane; Exhaled breath condensate; Safety; Ventilation

Indexed keywords

8 ISOPROSTANE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EXPIRED AIR; FEASIBILITY STUDY; FEMALE; HUMAN; HUMIDIFIER; IN VITRO STUDY; INFANT; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATIENT SAFETY; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; SAMPLING; STANDARDIZATION; TIME; VENTILATOR; WATER VAPOR;

AIR; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; DINOPROST; EXHALATION; FEMALE; HUMANS; INFANT; MALE; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS;

EID: 33751282873     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00063505     Document Type: Article

References (39)

1. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722.
2. Burmester M, Mok Q. How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children? Intensive Care Med 2001; 27: 716-721.
3. Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002; 165: 663-669.
4. Gauvin F, Lacroix J, Guertin MC, et al. Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated children. Am J Respir Crit Care Med 2002; 165: 1618-1623.
5. Olivieri D, D'Ippolito R, Chetta A. Induced sputum: diagnostic value in interstitial lung disease. Curr Opin Pulm Med 2000; 6: 411-414.
6. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med Wkly 2004; 134: 175-192.
7. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58: 505-509.
8. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002; 122: Suppl. 6, 314S-320S.
9. Pavord ID. Sputum induction to assess airway inflammation: is it an inflammatory stimulus? Thorax 1998; 53: 79-80.
10. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164: 731-737.
11. Effros RM, Dunning MB III, Biller J, Sharker R. The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1073-L1080.
12. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1: 11-14.
13. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114: 1653-1659.
14. Gessner C, Hammerschmidt S, Kuhn H, et al. Exhaled breath condensate acidification in acute lung injury. Respir Med 2003; 97: 1188-1194.
15. Kietzmann D, Kahl R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19: 78-81.
16. Moloney ED, Mumby SE, Gajdocsi R, et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am J Respir Crit Care Med 2004; 169: 64-69.
17. Cheah FC, Darlow BA, Winterbourn CC. Problems associated with collecting breath condensate for the measurement of exhaled hydrogen peroxide from neonates on respiratory support. Biol Neonate 2003; 84: 338-341.
18. Hitka P, Cerny M, Vizek M, Wilhelm J, Zoban P. Assessment of exhaled gases in ventilated preterm infants. Physiol Res 2004; 53: 561-564.
19. Nycyk JA, Drury JA, Cooke RW. Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 79: F67-F69.
20. Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
21. Baraldi E, Ghiro L, Piovan V, et al. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88: 358-360.
22. McCafferty JB, Bradshaw TA, Tate S, Greening AP, Inns JA. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 2004; 59: 694-698.
23. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000; 55: 205-209.
24. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H, Jorres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 1115-1118.
25. e scale simplify the presentation of log transformed data. Stat Med 2000; 19: 3109-3125.
26. Hertz MI, Woodward ME, Gross CR, Swart M, Marcy TW, Bitterman PB. Safety of bronchoalveolar lavage in the critically ill, mechanically ventilated patient. Crit Care Med 1991; 19: 1526-1532.
27. Shields MD, Riedler J. Bronchoalveolar lavage and tracheal aspirate for assessing airway inflammation in children. Am J Respir Crit Care Med 2000; 162: S15-S17.
28. Kotecha S. Bronchoalveolar lavage of newborn infants. Pediatr Pulmonol Suppl 1999; 18: 122-124.
29. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148: 556-561.
30. Klech H, Hutter C. Side-effects and safety of BAL. Eur Respir J 1990; 3: 939-940.
31. 2 monitoring. Pneumologie 1998; 52: 157-160.
32. Belai YZ, Findlay RD, Lau AS, Walther FJ. Bronchoalveolar lavage in ventilated newborn infants: safety and tumor necrosis factor-α activity. J Perinatol 1997; 17: 360-365.
33. Balk RA, Bradsher RW Jr, Jacobs RF, et al. Bacteremia during bronchoalveolar lavage. South Med J 1986; 79: 1496-1498.
34. Whittle AT, Davis M, Johnson PR, Leonard RC, Greening AP. The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia. Bone Marrow Transplant 1999; 24: 63-67.
35. Vaughan J, Ngamtrakulpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003; 22: 889-894.
36. Hyde RW. "I don't know what you guys are measuring but you sure are measuring it!" A fair criticism of measurements of exhaled condensates? Am J Respir Crit Care Med 2002; 165: 561-562.
37. Gaston B. Breath condensate analysis: perhaps worth studying, after all. Am J Respir Crit Care Med 2003; 167: 292-293.
38. Effros RM, Gaston B, Mutti A, et al. Saving the breath condensate approach. Am J Respir Crit Care Med 2003; 168: 1129-1130.
39. Griese M, Noss J, Bredow CC. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002; 2: 690-696.